Serina Therapeutics
33 hedge funds and large institutions have $7.48M invested in Serina Therapeutics in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 5 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.02% less ownership
Funds ownership: 0.38% → 0.36% (-0.02%)
8% less funds holding
Funds holding: 36 → 33 (-3)
9% less capital invested
Capital invested by funds: $8.21M → $7.48M (-$732K)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$62.5K |
| 2 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$40.2K |
| 3 |
State Street
Boston,
Massachusetts
|
+$38.3K |
| 4 |
SWIG
Strategic Wealth Investment Group
Louisville,
Kentucky
|
+$8.58K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.81K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$364K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$85.6K |
| 3 |
Millennium Management
New York
|
-$30K |
| 4 |
ISB
Iowa State Bank
Urbandale,
Iowa
|
-$18K |
| 5 |
AWM
Avior Wealth Management
Omaha,
Nebraska
|
-$4K |
SER Hedge Fund Activity: Q2 2021 in Review
33 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q2 2021, worth a combined $7.48M — down 8.9% from $8.21M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of SER and 2 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 5 added.
The largest buyer was BlackRock, adding an estimated $62.5K. The largest seller was Renaissance Technologies, cutting an estimated $364K.
- 33 institutional investors held Serina Therapeutics (SER) as of Q2 2021, down from 36 in Q1 2021.
- Funds reported $7.48M of Serina Therapeutics stock for Q2 2021, down 8.9% quarter-over-quarter.
- 2 funds opened new Serina Therapeutics positions in Q2 2021 and 5 closed out, a net change of -3 holders.
- The largest Serina Therapeutics buyer in Q2 2021 was BlackRock, an estimated $62.5K added.
- The largest Serina Therapeutics seller in Q2 2021 was Renaissance Technologies, an estimated $364K sold.
Based on aggregated 13F filings for Q2 2021.